Probucol downregulates E-selectin expression on cultured human vascular endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 8, 1996, Pages 1047-1051

  Kaneko, Masayo ^a   Hayashi, Joichiro ^b   Saito, Ichiro ^a   Miyasaka, Nobuyuki ^c  

^a Medical Research Institute

^b School of Dentistry

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

atherosclerosis; cell adhesion molecule; E selectin; endothelial cell; probucol

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; PROBUCOL;

ANTIGEN EXPRESSION; ARTICLE; ATHEROSCLEROSIS; CELL ADHESION; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; PRIORITY JOURNAL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0029843992     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.8.1047     Document Type: Article

References (47)

1. Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor to neutrophils related to complement regulatory proteins and lectins. Science. 1989;243:1160-1165.
2. Montgomery KF, Osborn L, Hession C, Tizard R, Goff D, Vassallo C, Tarr PI, Bomsztyk K, Lobb R, Harlan JM. Activation of endothelial-leukocyte adhesion molecule-1 (ELAM-1) gene transcription. Proc Natl Acad Sci U S A. 1991;88:6523-6527.
3. Leeuwenberg JFM, Jeunhomme TMAA, Buurman WA. Role of ELAM-1 in adhesion of monocytes to activated human endothelial cells. Scand J Immunol. 1992;35:335-341.
4. Simmons D, Makgoba MW, Seed B. ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM. Nature. 1988;331:624-627.
5. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell. 1988;52:925-933.
6. Poston RN, Haskard DO, Coucher JR, Gall N, Johnson-Tidey RR. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol. 1992;140:665-673.
7. Shimizu Y, Shaw S, Graber N, Gopal TV, Horgan KJ, Van Seventur GA, Newman W. Activation-independent binding of human memory T cells to adhesion molecule ELAM-1. Nature. 1991;394:799-802.
8. Pober JS, Gimbrone MA Jr, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol. 1986;137:1893-1896.
9. Mulligan MS, Varani J, Dame MK, Lane CL, Smith CW, Anderson DC, Ward PA. Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats. J Clin Invest. 1991;88:1396-1406.
10. Munro JM, Pober JS, Cotran RS. Recruitment of neutrophils in the local endotoxin response: association with de novo endothelial expression of endothehal leukocyte adhesion molecule-1. Lab Invest. 1991;64:295-299.
11. Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell. 1990;62:3-6.
12. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 1990;251:788-791.
13. Davies MJ, Gordon JL, Gearing AJH, Pigott R, Woolf N, Katz D, Kyriakopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol. 1993;171:223-229.
14. Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A, Yoshida H, Kawai C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci U S A. 1987;84:5928-5931.
15. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci U S A. 1987;84:7725-7729.
16. Nagano Y, Nakamura T, Matsuzawa Y, Cho M, Ueda Y, Kita T. Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit: long-term antiatherogenic effect and effects on established plaques. Atherosclerosis. 1992;92:131-140.
17. Daugherty A, Zweifel BS, Schonfeld G. Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Br J Pharmacol. 1989;98:612-618.
18. O'Brien K, Nagano Y, Gown A, Kita T, Chait A. Probucol treatment affects the cellular composition but not antioxidized LDL immuno-reactivity of plaques from Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb. 1991;11:751-759.
19. Daugherty A, Zweifel BS, Schonfeld G. The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits. Br J Pharmacol. 1991;103:1013-1018.
20. Yamamoto A, Takaichi S, Hara H, Nishikawa O, Yokokyama S, Yamamura T, Yamagushi T. Probucol prevents lipid storage in macrophages. Atherosclerosis. 1986;62:209-217.
21. Baumann DS, Doblas M, Schonfeld G, Sicard GA, Daugherty A. Probucol reduces the cellularity of aortic intimal thickening at anastomotic regions adjacent to prosthetic grafts in cholesterol-fed rabbits. Anerioscler Thromb. 1994;14:162-167.
22. Ferns GAA, Forster L, Stewart-Lee A, Nourooz-Zadeh J, Anggard EE. Probucol inhibits mononuclear cell adhesion to vascular endothelium in the cholesterol-fed rabbit. Atherosclerosis. 1993;100:171-181.
23. Jaffe EA, Nachman RN, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologie criteria. J Clin Invest. 1973;52:2745-2756.
24. Miyasaka N, Inoue H, Totsuka T, Koike R, Kino K, Tsunoo H. An immunomodulatory protein, ling zhi-8 (LZ-8), facilitates cellular interaction through modulation of adhesion molecules. Biochem Biophys Res Commun. 1992;186:385-390.
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
26. Buckley MMT, Goa KL, Price AH, Brogden RN. Probucol: a reappraisal of its pharmacological properties and therapeutic use in hypercholesterolemia. Drugs. 1989;37:761-800.
27. Parthasarathy S, Young SG, Witztum JL, Pittman RC, Steinberg D. Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest. 1986;77:641-644.
28. Ku G, Doherty NS, Schmidt LF, Jackson RL, Dinerstein RJ. Ex vivo lipopolysaccharide-induced interleukin-1 secretion from murine peritoneal macrophages inhibited by probucol, a hypocholesterolemic agent with antioxidant properties. FASEB J. 1990;4:1645-1653.
29. Ku G, Doherty NS, Wolos JA, Jackson RL, Schmidt LF, Hendricks D. Inhibition by probucol of interleukin 1 secretion and its implication in atherosclerosis. Am J Cardiol. 1988;62:77B-81B.
30. Franceschini G, Sirtori M, Vaccarino V, Gianfranceschi G, Rezzonico L, Chiesa G, Sirtori CR. Mechanisms of HDL reduction after probucol: changes in HDL subfractions and increased reverse cholesteryl ester transfer. Arteriosclerosis. 1989;9:462-469.
31. Franceschini G, Chiesa G, Sirtori CR. Probucol increases cholesteryl ester transfer protein activity in hypercholesterolaemic patients. Eur J Clin Invest. 1991;21:384-388.
32. Faruqi R, Motte C, DiCorleto PE. α-Tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest. 1994;94:592-600.
33. Wood KM, Cadogan MD, Ramshaw AL, Parums DV. The distribution of adhesion molecules in human atherosclerosis. Histopathology. 1993;22:437-444.
34. Graber N, Gopal V, Wilson D, Beall DL, Polte T, Newman W. T cells bind to cytokine-activated endothelial cells via a novel, inducible sialoglycoprotein and endothelial leukocyte adhesion molecule-1. J Immunol. 1990;145:819-830.
35. Ramshaw AL, Parums DV. Immunohistochemical characterization of inflammatory cells associated with advanced atherosclerosis. Histopathology. 1990;17:543-552.
36. Shimizu Y, Newman W, Gopal TV, Morgan KJ, Graber N, Beall LD, van Seveter GA, Shaw S. Four molecular pathways of T cell adhesion to endothelial cells: roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions. J Cell Biol. 1991;113:1203-1212.
37. van der Wal AC, Das PK, Tigges AJ, Becker AE. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol. 1992;141:1427-1433.
38. Ramshaw AL, Parums DV. The distribution of adhesion molecules in chronic periaortitis. Histopathology. 1994;24:23-32.
39. Carlos TM, Kovach N, Schwartz B, Rosa M, Newman B, Wayner E, Benjamin C, Osborn L, Lobb R, Harlan J. Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: endothelial leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1. Blood. 1991;77:2266-2270.
40. Spertini O, Luscinskas FW, Gimbrone MA, Tedder TF. Monocyte attachment to activated human vascular endothelium is mediated by leukocyte adhesion molecule-1 (L-selectin) under nonstatic conditions. J Exp Med. 1992;175:1789-1792.
41. Grober JS, Bowen BJ, Ebling H, Athey B, Thompson CB, Fox DA, Stoolman LM. Monocyte-endothelial adhesion in chronic rheumatoid arthritis: in situ detection of selectin and integrin-dependent interactions. J Clin Invest. 1993;91:2609-2619.
42. Weber C, Negrescu E, Erl W, Pietsch A, Frankenberger M, Ziegler-Heitbrock HWL, Siess W, Weber PC. Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules. J Immunol. 1995;155:445-451.
43. Bevilacqua MP, Nelson RM. Selectins. J Clin Invest. 1993;91:379-387.
44. Munro JM. Endothelial-leukocyte adhesion interactions in inflammatory diseases. Eur Heart J. 1993;14:72-77.
45. Koike R, Miki I, Otoshi M, Totsuka T, Inoue H, Kase H, Saito I, Miyasaka N. Gold sodium thiomalate down-regulates intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression on vascular endothelial cells. Mol Pharmacol. 1994;46:599-604.
46. Jurgensen CH, Huber BE, Zimmerman TP, Wolberg G. 3-Deaza-adenosine inhibits leukocyte adhesion and ICAM-1 biosynthesis in tumor necrosis factor-stimulated human endothelial cells. J Immunol. 1990;144:653-661.
47. Shankar R, de la Motte CA, DiCorleto PE. 3-Deazaadenosine inhibits thrombin-stimulated platelet-derived growth factor production and endothelial-leukocyte adhesion molecule-1-mediated monocytic cell adhesion in human aortic endothelial cells. J Biol Chem. 1992;267:9376-9382.